155 related articles for article (PubMed ID: 28532005)
21. We still have a long way to go to effectively deliver genes!
Pezzoli D; Chiesa R; De Nardo L; Candiani G
J Appl Biomater Funct Mater; 2012 Sep; 10(2):82-91. PubMed ID: 23015375
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS.
Johansen J; Rosenblad C; Andsberg K; Møller A; Lundberg C; Björlund A; Johansen TE
Gene Ther; 2002 Oct; 9(19):1291-301. PubMed ID: 12224012
[TBL] [Abstract][Full Text] [Related]
23. Hybrid vector designs to control the delivery, fate and expression of transgenes.
Lam PY; Breakefield XO
J Gene Med; 2000; 2(6):395-408. PubMed ID: 11199260
[TBL] [Abstract][Full Text] [Related]
24. Stent-mediated gene delivery for site-specific transgene administration to the airway epithelium and management of tracheobronchial tumors.
Kruklitis RJ; Fishbein I; Singhal S; Kapoor V; Levy RJ; Alferiev IS; Sterman DH
Respiration; 2014; 88(5):406-17. PubMed ID: 25323160
[TBL] [Abstract][Full Text] [Related]
25. Sleeping Beauty-baculovirus hybrid vectors for long-term gene expression in the eye.
Turunen TA; Laakkonen JP; Alasaarela L; Airenne KJ; Ylä-Herttuala S
J Gene Med; 2014; 16(1-2):40-53. PubMed ID: 24464652
[TBL] [Abstract][Full Text] [Related]
26. Non-viral ocular gene therapy: potential ocular therapeutic avenues.
Bloquel C; Bourges JL; Touchard E; Berdugo M; BenEzra D; Behar-Cohen F
Adv Drug Deliv Rev; 2006 Nov; 58(11):1224-42. PubMed ID: 17095114
[TBL] [Abstract][Full Text] [Related]
27. Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications.
Schön C; Biel M; Michalakis S
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):343-52. PubMed ID: 25615882
[TBL] [Abstract][Full Text] [Related]
28. Pseudotyped recombinant adeno-associated viral vectors mediate efficient gene transfer into primary human CD34(+) peripheral blood progenitor cells.
Veldwijk MR; Sellner L; Stiefelhagen M; Kleinschmidt JA; Laufs S; Topaly J; Fruehauf S; Zeller WJ; Wenz F
Cytotherapy; 2010; 12(1):107-12. PubMed ID: 19929455
[TBL] [Abstract][Full Text] [Related]
29. Gene transfer in inner ear cells: a challenging race.
Sacheli R; Delacroix L; Vandenackerveken P; Nguyen L; Malgrange B
Gene Ther; 2013 Mar; 20(3):237-47. PubMed ID: 22739386
[TBL] [Abstract][Full Text] [Related]
30. Efficiency of RAFT-synthesized PDMAEMA in gene transfer to the retina.
Bitoque DB; Simão S; Oliveira AV; Machado S; Duran MR; Lopes E; da Costa AM; Silva GA
J Tissue Eng Regen Med; 2017 Jan; 11(1):265-275. PubMed ID: 24934519
[TBL] [Abstract][Full Text] [Related]
31. Repeated administration of adenovector in the eye results in efficient gene delivery.
Hamilton MM; Brough DE; McVey D; Bruder JT; King CR; Wei LL
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):299-305. PubMed ID: 16384977
[TBL] [Abstract][Full Text] [Related]
32. Utility of intraperitoneal administration as a route of AAV serotype 5 vector-mediated neonatal gene transfer.
Ogura T; Mizukami H; Mimuro J; Madoiwa S; Okada T; Matsushita T; Urabe M; Kume A; Hamada H; Yoshikawa H; Sakata Y; Ozawa K
J Gene Med; 2006 Aug; 8(8):990-7. PubMed ID: 16685745
[TBL] [Abstract][Full Text] [Related]
33. Nonviral gene delivery: what we know and what is next.
Gao X; Kim KS; Liu D
AAPS J; 2007 Mar; 9(1):E92-104. PubMed ID: 17408239
[TBL] [Abstract][Full Text] [Related]
34. Dendrimers for gene delivery--a potential approach for ocular therapy?
Chaplot SP; Rupenthal ID
J Pharm Pharmacol; 2014 Apr; 66(4):542-56. PubMed ID: 24635556
[TBL] [Abstract][Full Text] [Related]
35. Progress and challenges in viral vector-mediated gene transfer to the brain.
Lowenstein PR; Castro MG
Curr Opin Mol Ther; 2002 Aug; 4(4):359-71. PubMed ID: 12222874
[TBL] [Abstract][Full Text] [Related]
36. Adenoviral vectors for liver-directed gene therapy.
Connelly S
Curr Opin Mol Ther; 1999 Oct; 1(5):565-72. PubMed ID: 11249663
[TBL] [Abstract][Full Text] [Related]
37. [Gene therapy: new developments].
Mohr L; Geissler M
Praxis (Bern 1994); 2002 Dec; 91(51-52):2227-35. PubMed ID: 12564039
[TBL] [Abstract][Full Text] [Related]
38. Non-viral and viral vectors for gene therapy.
Boulaiz H; Marchal JA; Prados J; Melguizo C; Aránega A
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(1):3-22. PubMed ID: 16171561
[TBL] [Abstract][Full Text] [Related]
39. Gene delivery to the juvenile mouse liver using AAV2/8 vectors.
Cunningham SC; Dane AP; Spinoulas A; Logan GJ; Alexander IE
Mol Ther; 2008 Jun; 16(6):1081-8. PubMed ID: 18414478
[TBL] [Abstract][Full Text] [Related]
40. Tightly-wound miniknot vectors for gene therapy: a potential improvement over supercoiled minicircle DNA.
Tolmachov OE
Med Hypotheses; 2010 Apr; 74(4):702-4. PubMed ID: 19914006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
